KRM Ayurveda Limited Reports Strong Q1 FY27 Results with Near 500% YoY Growth in EBITDA
KRM Ayurveda Limited has reported a robust first quarter for fiscal year 2027 (Q1 FY27), showcasing significant growth across key financial metrics. The company recorded Total Income of 3,286.55 Lakhs, while Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) rose by 497.4% year-on-year (YoY) to reach 1,256.07 Lakhs.The company’s Net Profit After Tax (PAT) stood at 908.45 Lakhs, marking a healthy growth of 124.2% YoY and 16.3% sequentially. These strong results underscore the increasing profitability within KRM Ayurveda Limited's integrated Ayurvedic healthcare and wellness segment.
Q1 FY27 Financial Performance Snapshot
KRM Ayurveda recorded Total Income of 3,286.55 Lakhs for the quarter ending June 30, 2026. This represented a 32.4% increase compared to the previous period, with EBITDA climbing substantially at 1,256.07 Lakhs.The company's operational performance details are presented in the table below:
| Metric | Q1 FY27 (Lakhs) | Previous Period (Lakhs) | Change YOY (%) |
|---|---|---|---|
| Total Income | 3,286.55 | 2,481.63 | +32.4% |
| EBITDA | 1,256.07 | 636.44 | +97.4% |
| Net Profit (PAT) | 908.45 | 405.28 | +124.2% |
| Revenue from Operations | 3,232.26 | 2,466.64 | +31.0% |
| Total Expenses | 2,063.06 | 1,939.49 | +6.4% |
Key Profitability and Operational Insights
KRM Ayurveda Limited demonstrated strong profitability margins for the quarter. The EBITDA margin reached 38.22% of total income, a substantial increase compared to previous periods. Similarly, the PAT margin stood at 27.64%, reflecting significant improvement in net profit conversion.The company also reported key additions contributing to its hospital and services capacity-led growth. Operational increases include:
- Hospitals added: 2
- Clinics added: 1
- Beds added: 103
KRMAYURVED Stock Price Movement
KRM Ayurveda Limited shares rallied today, closing in strong territory at ₹329.80 after gaining 6.95%. The stock saw a robust trading day and traded within the range of ₹312 to ₹343.95, with 240,000 shares accounted for.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.